Role of Enoxaparin in the Management of STEMI: An Indian Perspective

Autores

  • Dr. Binu M.G Associate Professor of Medicine, Fatima Institute of Medical Sciences, Kadappa, Andhra Pradesh
  • Dr. Manoj P.

Palavras-chave:

Unfractionated heparin (UFH), low molecular weight heparin (LMWH), acute coronary syndrome (ACS), ST-elevation myocardial infarction (STEMI)

Resumo

Cardiovascular diseases are major causes of morbidity and mortality worldwide. Acute coronary syndrome is one of the main causes of hospital admissions. ST-elevation myocardial infarction is the severe dreaded ACS causing morbidity and mortality. Probably because of economic reasons, conventional heparin continues to be the main anticoagulant therapy in STEMI. Enoxaparin is safe and effective in the treatment of ST-elevation myocardial infarction. Various studies outline its efficacy and safety in STEMI. The benefits of enoxaparin outweigh the minor risk of hemorrhages noted with its use. The cost of therapy is high for an average Indian patient. The biosimilar enoxaparin needs to be studied well before it can be deemed equivalent to the original molecule.

Biografia do Autor

  • Dr. Binu M.G, Associate Professor of Medicine, Fatima Institute of Medical Sciences, Kadappa, Andhra Pradesh
    Associate professor in General Medicine, 

Downloads

Publicado

2012-04-03

Edição

Vol. 2 N.º 1 (2012)

Secção

Review Articles

Licença

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

·         I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.

·         I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).

·         I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.

·          I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

_______________

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.